|
1
|
Siegel R, Ma J, Zhou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar
|
|
2
|
Palmer TD, Ashby WJ, Lewis JD and Zijlstra
A: Targeting tumor cell motility to prevent metastasis. Adv Drug
Deliv Rev. 63:568–581. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fishman DA, Kearns A, Chilukuri K, et al:
Metastatic dissemination of human ovarian epithelial carcinoma is
promoted by α2β1-integrin-mediated interaction with type I
collagen. Invasion Metastasis. 18:15–26. 1998.
|
|
4
|
Hynes RO: Integrins: bidirectional,
allosteric signaling machines. Cell. 110:673–687. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Geiger B, Spatz JP and Bershadsky AD:
Environmental sensing through focal adhesions. Nat Rev Mol Cell
Biol. 10:21–33. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grashoff C, Hoffman BD, Brenner MD, et al:
Measuring mechanical tension across vinculin reveals regulation of
focal adhesion dynamics. Nature. 466:263–266. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hodivala-Dilke KM, McHugh KP, Tsakiris DA,
et al: β3-integr-indeficient mice are a model for Glanzmann
thrombasthenia showing placental defects and reduced survival. J
Clin Invest. 103:229–238. 1999.
|
|
8
|
Ridley AJ: Rho GTPases and actin dynamics
in membrane protrusions and vesicle trafficking. Trends Cell Biol.
16:522–529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spiering D and Hodgson L: Dynamics of the
Rho-family small GTPases in actin regulation and motility. Cell Adh
Migr. 5:170–180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
van Horssen R, Galjart N, Rens JA,
Eggermont AM and ten Hagen TL: Differential effects of matrix and
growth factors on endothelial and fibroblast motility: application
of a modified cell migration assay. J Cell Biochem. 99:1536–1552.
2006.PubMed/NCBI
|
|
11
|
Vorotnikov AV: Chemotaxis: movement,
direction, control. Biochemistry (Mosc). 76:1528–1555. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vicente-Manzanares M, Webb DJ and Horwitz
AR: Cell migration at a glance. J Cell Sci. 118:4917–4919. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arias-Romero LE and Chernoff J: A tale of
two Paks. Biol Cell. 100:97–108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Manser E, Leung T, Salihuddin H, Zhao ZS
and Lim L: A brain serine/threonine protein kinase activated by
Cdc42 and Rac1. Nature. 367:40–46. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edwards DC, Sanders LC, Bokoch GM and Gill
GN: Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase
signalling to actin cytoskeletal dynamics. Nat Cell Biol.
1:253–259. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chew TL, Masaracchia RA, Goeckeler ZM and
Wysolmerski RB: Phosphorylation of non-muscle myosin II regulatory
light chain by p21-activated kinase (γ-PAK). J Muscle Res Cell
Motil. 19:839–854. 1998.
|
|
17
|
Sanders LC, Matsumura F, Bokoch GM and de
Lanerolle P: Inhibition of myosin light chain kinase by
p21-activated kinase. Science. 283:2083–2085. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Manser E, Huang HY, Loo TH, Chen XQ, Dong
JM, Leung T and Lim L: Expression of constitutively active α-PAK
reveals effects of the kinase on actin and focal complexes. Mol
Cell Biol. 17:1129–1143. 1997.
|
|
19
|
Nayal A, Webb DJ, Brown CM, Schaefer EM,
Vicente-Manzanares M and Horwitz AR: Paxillin phosphorylation at
Ser273 localizes a GIT1-PIX-PAK complex and regulates adhesion and
protrusion dynamics. J Cell Biol. 173:587–589. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bokoch GM: Biology of the p21-activated
kinases. Ann Rev Biochem. 72:743–781. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kumar R, Gururaj AE and Barnes CJ:
p21-activated kinases in cancer. Nat Rev Cancer. 6:459–471. 2006.
View Article : Google Scholar
|
|
22
|
Di Saida PJ, Sinkovics JG, Rutledge FN and
Smith JP: Cell mediated immunity to human malignant cells. Am J
Obstet Gynecol. 114:979–989. 1972.
|
|
23
|
Andrews PA, Muphy MP and Howell SB:
Differential potentiation of alkylating and platinating agent
cytotoxicity in human ovarian carcinoma cells by glutathione
depletion. Cancer Res. 45:6250–6253. 1985.
|
|
24
|
Shen Y, Shen R, Ge L, Zhu Q and Li F:
Fibrillar type I collagen matrices enhance metastasis/invasion of
ovarian epithelial cancer via beta1 integrin and PTEN signals. Int
J Gynecol Cancer. 22:1316–1324. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ahmed N, Riley C, Rice G and Quinn M: Role
of integrin receptors for fibronectin, collagen and laminin in the
regulation of ovarian carcinoma functions in response to a matrix
microenvironment. Clin Exp Metastasis. 22:391–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Petrie RJ, Doyle AD and Yamada KM: Random
versus directionally persistent cell migration. Nat Rev Mol Cell
Biol. 10:538–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mochizuki Y, Nakanishi H, Kodera Y, et al:
TNF-alpha promotes progression of peritoneal metastasis as
demonstrated using a green fluorescence protein (GFP)-tagged human
gastric cancer cell line. Clin Exp Metastasis. 21:39–47. 2004.
View Article : Google Scholar
|
|
28
|
Burleson KM, Hansen LK and Skubitz AP:
Ovarian carcinoma spheroids disaggregate on type I collagen and
invade live human mesothelial cell monolayers. Clin Exp Metastasis.
21:685–697. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moser TL, Pizzo SV, Bafetti LM, Fishman DA
and Stack MS: Evidence for prefer-ential adhesion of ovarian
epithelial carcinoma cells to type I collagen mediated by the α2β1
integrin. Int J Cancer. 67:695–701. 1996.PubMed/NCBI
|
|
30
|
Rieppi M, Vergani V, Gatto C, Zanetta G,
Allavena P, Taraboletti G and Giavazzi R: Mesothelial cells induce
the motility of human ovarian carcinoma cells. Int J Cancer.
80:303–307. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ryschich E, Khamidjanov A, Kerkadze V,
Büchler MW, Zöller M and Schmidt J: Promotion of tumor cell
migration by extracellular matrix proteins in human pancreatic
cancer. Pancreas. 38:804–810. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maity G, Choudhury PR, Sen T, Ganguly KK,
Sil H and Chatterjee A: Culture of human breast cancer cell line
(MDA-MB -231) on fibronectin-coated surface induces pro-matrix
metalloproteinase-9 expression and activity. Tumour Biol.
32:129–138. 2011. View Article : Google Scholar
|
|
33
|
Urtreger AJ, Werbajh SE, Verrecchia F, et
al: Fibronectin is distinctly downregulated in murine mammary
adenocarcinoma cells with high metastatic potential. Oncol Rep.
16:1403–1410. 2006.PubMed/NCBI
|
|
34
|
Zhao H, Jhanwar-Uniyal M and Datta PK:
Expression profile of genes associated with anti-metastatic gene:
nm23-mediated metastasis inhibition in breast carcinoma cells. Int
J Cancer. 109:65–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Akamatsu H, Ichihara-Tanaka K, Ozono K,
Kamiike W, Matsuda H and Sekiguchi K: Suppression of transformed
phenotypes of human fibrosarcoma cells by overexpression of
recombinant fibronectin. Cancer Res. 56:4541–4546. 1996.PubMed/NCBI
|
|
36
|
Der CJ and Stanbridge EJ: Alterations in
the extracellular matrix organization associated with the
reexpression of tumorigenicity in human cell hybrids. Int J Cancer.
26:451–459. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jiao Y, Feng X, Zhan Y, Wang R, Zheng S,
Liu W and Zeng X: Matrix metalloproteinase-2 promotes αVβ3
integrin-mediated adhesion and migration of human melanoma cells by
cleaving fibronectin. PloS One. 7:1–12. 2012.
|
|
38
|
Kenny HA and Lengyel E: MMP-2 functions as
an early response protein in ovarian cancer metastasis. Cell Cycle.
8:683–688. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cox EA, Sastry SK and Huttenlocher A:
Integrin-mediated adhesion regulates cell polarity and membrane
protrusion through the Rho family of GTPases. Mol Biol Cell.
12:265–277. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Deacon SW, Beeser A, Fukui JA, Rennefahrt
UE, Myers C, Chernoff J and Peterson JR: An isoform-selective,
small-molecule inhibitor targets the autoregulatory mechanism of
p21-activated kinase. Chem Biol. 15:322–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Coniglio SJ, Zavarella S and Symons MH:
Pak1 and Pak2 mediate tumor cell invasion through distinct
signaling mechanisms. Mol Cell Biol. 28:4162–4172. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bright MD, Garner AP and Ridley AJ: PAK1
and PAK2 have different roles in HGF-induced morphological
responses. Cell Signal. 21:1738–1747. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Siu MK, Wong ES, Chan HY, et al:
Differential expression and phosphorylation of Pak1 and Pak2 in
ovarian cancer: effects on prognosis and cell invasion. Int J
Cancer. 127:21–31. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sato M, Matsuda Y, Wakai T, et al:
P21-activated kinase-2 is a critical mediator of transforming
growth factor-β-induced hepatoma cell migration. J Gastroenterol
Hepatol. 28:1047–1055. 2013.PubMed/NCBI
|
|
45
|
Gadepalli R, Kotla S, Heckle MR, Verma SK,
Singh NK and Rao GN: Novel role for p21-activated kinase 2 in
thrombin-induced monocyte migration. J Biol Chem. 288:30815–30831.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Huttenlocher A and Horwitz AR: Integrins
in cell migration. Cold Spring Harb Perspect Biol. 3:a0050742011.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Cram EJ, Clark SG and Schwarzbauer JE:
Talin loss-of-function uncovers roles in cell contractility and
migration in C. elegans. J Cell Sci. 116:3871–3878. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ashby WJ and Zijlstra A: Established and
novel methods of interrogating two-dimensional cell migration.
Integr Biol (Camb). 4:1338–1350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lauffenburger DA and Horwitz AF: Cell
migration: a physically integrated molecular process. Cell.
84:359–369. 1996. View Article : Google Scholar : PubMed/NCBI
|
